- Home
- STAF vs REVB Comparison
STAF vs REVB Comparison
Compare STAF & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAF
- REVB
- Stock Information
- Founded
- STAF 2009
- REVB 2020
- Country
- STAF United States
- REVB United States
- Employees
- STAF N/A
- REVB N/A
- Industry
- STAF Professional Services
- REVB Biotechnology: Pharmaceutical Preparations
- Sector
- STAF Consumer Discretionary
- REVB Health Care
- Exchange
- STAF Nasdaq
- REVB Nasdaq
- Market Cap
- STAF 1.2M
- REVB 1.4M
- IPO Year
- STAF N/A
- REVB N/A
- Fundamental
- Price
- STAF $2.07
- REVB $0.30
- Analyst Decision
- STAF
- REVB
- Analyst Count
- STAF 0
- REVB 0
- Target Price
- STAF N/A
- REVB N/A
- AVG Volume (30 Days)
- STAF 52.6K
- REVB 1.7M
- Earning Date
- STAF 01-08-2025
- REVB 11-08-2024
- Dividend Yield
- STAF N/A
- REVB N/A
- EPS Growth
- STAF N/A
- REVB N/A
- EPS
- STAF N/A
- REVB N/A
- Revenue
- STAF $176,819,000.00
- REVB N/A
- Revenue This Year
- STAF $1.94
- REVB N/A
- Revenue Next Year
- STAF $8.38
- REVB N/A
- P/E Ratio
- STAF N/A
- REVB N/A
- Revenue Growth
- STAF 13.64
- REVB N/A
- 52 Week Low
- STAF $1.08
- REVB $0.30
- 52 Week High
- STAF $5.69
- REVB $25.26
- Technical
- Relative Strength Index (RSI)
- STAF 42.17
- REVB 24.91
- Support Level
- STAF $2.07
- REVB $0.32
- Resistance Level
- STAF $2.41
- REVB $0.37
- Average True Range (ATR)
- STAF 0.18
- REVB 0.07
- MACD
- STAF -0.03
- REVB -0.01
- Stochastic Oscillator
- STAF 11.11
- REVB 0.00
About STAF Staffing 360 Solutions Inc. (DE)
Staffing 360 Solutions Inc operates in the international staffing sector. It is engaged in the execution of an international buy-integrate-build process through the acquisition of domestic and international staffing organizations. The company operates through three Business Streams: Professional Staffing, Commercial Staffing, and Employer of Record. It primarily supports accounting and finance, information technology, engineering, administration, and commercial disciplines.
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).